“From Hyderabad to the World: How Sensa Core Is Powering India’s Diagnostic Revolution with a $72M Funding Boost”
“From Hyderabad to the World: How Sensa Core Is Powering India’s Diagnostic Revolution with a $72M Funding Boost”
In the race to democratize healthcare, diagnostics is where life-saving decisions are made. Amidst this backdrop, Sensa Core Medical Instrumentation is emerging as one of India’s most promising homegrown leaders in medical diagnostics — combining deep technological expertise, rapid innovation, and strategic funding to expand its global footprint.
The Big News: $72 Million Funding to Fuel Global Growth
In a landmark development for India’s medtech sector, Motilal Oswal Alternates, the private equity arm of Motilal Oswal Financial Services, announced a major investment of USD 72 million (approx. ₹645 crore) into Sensa Core Medical Instrumentation in December 2025. This investment secured a significant minority stake in the company and underscores investor confidence in India-made diagnostic technologies.
The capital infusion will be strategically deployed to accelerate product innovation, expand manufacturing capacity, and scale the company’s global reach, especially in point-of-care (POC) and in-vitro diagnostic (IVD) solutions.
Rohit Mantri, Managing Director at Motilal Oswal Alternates, emphasized that the partnership reflects a broader commitment to nurture indigenous healthcare solutions in a market where over 75% of medical devices are currently imported.
About Sensa Core: A Homegrown MedTech Powerhouse
Founded in 2006 in Hyderabad by Dr. Ravi Kumar Meruva, Sensa Core has evolved from a bootstrapped startup into a comprehensive diagnostics manufacturer with a strong global presence.
The company specializes in the design, development, manufacturing, and distribution of specialized in-vitro diagnostic devices, including:
-
Electrolyte analysers — widely adopted across Indian hospitals and labs
-
Glucometers and haemoglobin meters
-
Arterial blood gas (ABG) analysers — for critical care environments
Its products are already installed in 40,000+ healthcare facilities in India, and the company exports to over 78 countries, demonstrating strong international market traction.
Manufacturing & Expansion: Strengthening India’s MedTech Backbone
With the new funds, Sensa Core will accelerate operations at its primary manufacturing facility in Hyderabad’s Export Promotion Industrial Park, Pashamylaram, and expand capacity with a new unit at the Medical Device Park in Sultanpur, Hyderabad.
These expansions are crucial not just for production scale-up but also for next-generation diagnostic product rollouts, including advanced POC technologies that bring critical analytics closer to patients.
Leadership & Vision: Innovation at the Core
Dr. Ravi Kumar Meruva, Founder & Managing Director, brings over three decades of experience in electrochemistry, system design, and applied medical technology to Sensa Core’s R&D efforts — blending industrial design, engineering, software, and chemistry into high-precision diagnostics.
Under his leadership, the company has prioritized IP-driven development and automation, positioning itself to compete with global players while maintaining a focus on cost efficiency and quality.
Why This Matters: India’s MedTech Moment
India remains heavily reliant on imported medical devices, with annual imports exceeding USD 8.5 billion — a gap that companies like Sensa Core are uniquely poised to address through localized innovation and manufacturing.
The recent funding not only strengthens Sensa Core’s balance sheet but also signals increased appetite from institutional investors for Indian medtech firms with global potential.
Looking Ahead: Empowering Diagnosis Everywhere
As Sensa Core transitions into its next growth phase, the company is expected to:
Expand product lines into more advanced diagnostic categories
Automate manufacturing for scalable and quality-consistent output
Strengthen global distribution across emerging and developed markets
Enhance R&D capabilities to push innovative point-of-care solutions
Conclusion
Sensa Core Medical Instrumentation’s $72 million funding milestone marks a pivotal chapter in both the company’s journey and the broader Indian medtech ecosystem. With strategic backing, robust manufacturing plans, and an innovation-first mindset, the Hyderabad-based diagnostics leader is poised to make “Made in India” synonymous with global excellence in healthcare diagnostics.
